StarkAge Therapeutics
PrivateLast Round
VC Round
May 29, 2024
Total Funding Raised
$2.27M
Company Overview
StarkAge Therapeutics operates in Healthcare & Life Sciences and is based in Lille. Its latest recorded funding round was a VC Round in May 2024.
StarkAge Therapeutics is a biotechnology company that develops first-in-class senolytic antibody–drug conjugates to address age-related diseases with an initial focus on oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StarkAge Therapeutics Comparables
Compare StarkAge Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cleara Biotech | 87% | |
| Deciduous Therapeutics | 86% | |
| Rubedo Life Sciences | 85% |
For institutional investors. Book with your work email.
StarkAge Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 29, 2024 | ||||
| Grant | Jan 19, 2022 |
For institutional investors. Book with your work email.
StarkAge Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Grant, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 29, 2024
$1.3M raised with Bpifrance participation.
- Jan 19, 2022
$2.27M grant received from Bpifrance.
For institutional investors. Book with your work email.
StarkAge Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about StarkAge Therapeutics's valuation, stock price, and market status.
Is StarkAge Therapeutics a public or private company?
StarkAge Therapeutics is a private company.
What is the current stock price of StarkAge Therapeutics?
StarkAge Therapeutics is a private company, so its shares have no public market price. Caplight tracks StarkAge Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is StarkAge Therapeutics worth (valuation)?
Valuation information for StarkAge Therapeutics is not publicly available.
Can I buy StarkAge Therapeutics stock?
StarkAge Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was StarkAge Therapeutics's last funding round?
StarkAge Therapeutics's most recent funding round was VC Round on May 29, 2024.
Who are the main investors in StarkAge Therapeutics?
Key investors in StarkAge Therapeutics include Bpifrance.
Will StarkAge Therapeutics IPO soon?
No public IPO plans have been announced for StarkAge Therapeutics.
How can I track StarkAge Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in StarkAge Therapeutics's shares on secondary markets.